On the other hand, Jakubikova et al (10) showed that the cells in the side population analyzed by flow cytometry, which are considered to be cancer stem cells, are CD138-positive cells with clonogenic potential, while Hosen et al (36) reported that both CD138-positive and -negative lesions have the capacity to propagate MM in vivo. Here, SDC1 is linked to Miyoshi myopathy.